403 ENGOT-Ov41/GEICO 69-O/ANITA的初步结果，这是一项双盲安慰剂对照3期试验，评估了atezolizumab联合铂类化疗和维持性尼拉帕尼治疗无铂间隔大于6个月的复发性卵巢癌的效果

{"title":"403 ENGOT-Ov41/GEICO 69-O/ANITA的初步结果，这是一项双盲安慰剂对照3期试验，评估了atezolizumab联合铂类化疗和维持性尼拉帕尼治疗无铂间隔大于6个月的复发性卵巢癌的效果","authors":"Antonio González-Martín, M. J. Rubio-Pérez, Florian Heitz, R. Christensen, N. Colombo, T. Gorp, A. Oaknin, Alexandra Leary, Lydia Gaba, C. Lebreton, Luis Miguel De Sande González, M. Romeo, A. Redondo, M. Barretina-Ginesta, Alejandro Pérez-Fidalgo, A. Santaballa, María José Bermejo, I. Bruchim, I. Ray-Coquard, Frédéric Selle","doi":"10.1136/ijgc-2024-esgo.44","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517822,"journal":{"name":"Oral Sessions","volume":"69 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"403 Primary results from ENGOT-Ov41/GEICO 69-O/ANITA, a double-blind placebo-controlled phase 3 trial evaluating atezolizumab combined with platinum-based chemotherapy and maintenance niraparib for recurrent ovarian cancer with a platinum-free interval >6 months\",\"authors\":\"Antonio González-Martín, M. J. Rubio-Pérez, Florian Heitz, R. Christensen, N. Colombo, T. Gorp, A. Oaknin, Alexandra Leary, Lydia Gaba, C. Lebreton, Luis Miguel De Sande González, M. Romeo, A. Redondo, M. Barretina-Ginesta, Alejandro Pérez-Fidalgo, A. Santaballa, María José Bermejo, I. Bruchim, I. Ray-Coquard, Frédéric Selle\",\"doi\":\"10.1136/ijgc-2024-esgo.44\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517822,\"journal\":{\"name\":\"Oral Sessions\",\"volume\":\"69 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral Sessions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2024-esgo.44\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Sessions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2024-esgo.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}